A critique of the decision analysis for clinically localized prostate cancer.

[1]  J H Wasson,et al.  A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. , 1993, Archives of family medicine.

[2]  R. Thisted,et al.  Results of conservative management of clinically localized prostate cancer. , 1994, The New England journal of medicine.

[3]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  P. Scardino,et al.  The risk of dying of prostate cancer in patients with clinically localized disease. , 1991, The Journal of urology.

[5]  R. B. Smith,et al.  Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. , 1992, The Journal of urology.

[6]  M. Barry,et al.  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993, JAMA.

[7]  M. Cowen,et al.  A Markov model of the natural history of prostate cancer. , 1994, Journal of clinical epidemiology.

[8]  S G Pauker,et al.  The toss-up. , 1981, The New England journal of medicine.

[9]  S. Tanenbaum,et al.  What physicians know. , 1993, The New England journal of medicine.

[10]  S. Mills,et al.  Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival. , 1985, The Journal of urology.

[11]  J. de Haes,et al.  Utility Assessment in Cancer Patients , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  A W Partin,et al.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.

[13]  John G. Kemeny,et al.  Finite Markov chains , 1960 .

[14]  J R Beck,et al.  A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. , 1982, The American journal of medicine.

[15]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.